House Oversight Committee hearing “Assessing America’s Vaccine Safety Systems, Part 1. (Feb. 15, 2024) source
BIO Vice Chair (and incoming CEO) John F. Crowley speaks at the Reagan-Udall Foundation for the FDA workshop about qualifying biomarkers to support rare disease regulatory pathways. (Feb. 21, 2024) source
Genetic Medicines’ Path to Scalability for Patients and Investors source
Opportunities for Financing Your Company Through Series B and Beyond source
Tackling Challenges in Oncology Drug Discovery and Development source